China Resources Pharmaceutical Group Limited (HKG: 3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.43
-0.03 (-0.55%)
Dec 20, 2024, 4:08 PM HKT

China Resources Pharmaceutical Group Revenue

China Resources Pharmaceutical Group had revenue of 64.30B CNY in the quarter ending June 30, 2024, with 4.71% growth. This brings the company's revenue in the last twelve months to 250.48B, up 11.50% year-over-year. In the year 2023, China Resources Pharmaceutical Group had annual revenue of 244.70B with 12.16% growth.

Revenue (ttm)
250.48B CNY
Revenue Growth
+11.50%
P/S Ratio
0.13
Revenue / Employee
3.43M CNY
Employees
72,986
Market Cap
34.11B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023244.70B26.52B12.16%
Dec 31, 2022218.18B-18.62B-7.86%
Dec 31, 2021236.81B36.38B18.15%
Dec 31, 2020200.42B-4.03B-1.97%
Dec 31, 2019204.45B14.76B7.78%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

China Resources Pharmaceutical Group News

More News